This is not the most recent version of the article. View current version (4 NOV 2015)

Intervention Review

You have free access to this content

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

  1. Kana R Jat1,*,
  2. Dinesh K Walia2,
  3. Anju Khairwa3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 17 SEP 2013

Assessed as up-to-date: 11 SEP 2013

DOI: 10.1002/14651858.CD010288.pub2


How to Cite

Jat KR, Walia DK, Khairwa A. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2013, Issue 9. Art. No.: CD010288. DOI: 10.1002/14651858.CD010288.pub2.

Author Information

  1. 1

    All India Institute of Medical Sciences, Department of Pediatrics, New Delhi, Delhi, India

  2. 2

    Govt. Medical College and Hospital (GMCH), Department of Community Medicine, Chandigarh, Chandigarh UT, India

  3. 3

    Postgraduate Institute of Medical Education and Research (PGIMER), Department of Pathology, Chandigarh, Chandigarh UT, India

*Kana R Jat, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Delhi, 110029, India. drkanaram@gmail.com. drkanaram@yahoo.co.in.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 SEP 2013

SEARCH

This is not the most recent version of the article. View current version (04 NOV 2015)

[Figure 1]
Figure 1. Study flow diagram.
[Figure 2]
Figure 2. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Figure 3]
Figure 3. Risk of bias summary: review authors' judgements about each risk of bias item for each included study.